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Enzymatic enantiomeric resolution of phenylethylamines structurally related
to amphetamine†
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Both enantiomers of several phenylethylamines, structurally related to amphetamine, have been
prepared in good yields and excellent enantiomeric purity by enzymatic kinetic resolution using CAL-B
and ethyl methoxyacetate as the acyl donor. In the case of the 4-hydroxyderivative of amphetamine
(compound 4i), the S enantiomer racemized possibly in a dynamic kinetic resolution (DKR) under the
enzymatic conditions used.
Introduction
Optically pure amines are frequently used in the pharmaceu-
tical and agrochemical ﬁelds because of their broad range
of applications.1 They are used as resolving agents, chiral
auxiliaries and chiral synthons for the synthesis of many
bioactive compounds. The most established methods for the
enantioselective preparation of chiral amines are asymmetric
hydrogenation of acetamides and imines2 and the asymmet-
ric addition of carbanions to aldimines.3 However, when the
two separate enantiomers are required, the best strategy is
the resolution of the racemates by distillation or fractional
crystallization of the diastereomeric salts,4 or chromatographic
separation of diastereomeric amides.5 In this context, enzy-
matic synthesis has emerged in recent decades as a powerful
and recognized tool for the development of chemo-, regio-,
and stereoselective processes.6 Lipases have become one of the
most common catalysts because of their easy availability, reason-
able price, high stability, and versatility of action.7
It is well known that phenylethylamines are powerful stim-
ulants of the central nervous system. They interfere with the
peripheral nervous system and are able to induce the release of
noradrenaline, acting therefore as potent vasoconstrictors.8 In
addition, they are intermediates for the synthesis of compounds
of physiological interest, such as alkaloids and amino acids.
In this paper we present a successful, enantioselective synthesis
of both enantiomers of amphetamine and amphetamine-related
amines by enzymatic kinetic resolution using CAL-B and ethyl
methoxyacetate as the acyl donor in excellent ee. The availability
of both enantiomers is particularly relevant because very often
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the pharmacological activity of these amines is related to the
conﬁguration of the stereogenic center. Thus, for instance, the
(S)-(+)-enantiomer of amphetamine (4a, Scheme 1) displays ca.
5¥ greater psychostimulant activity than the (R)-(-)-form.9
Scheme 1 Approaches used for the synthesis of racemic amines 4a–4h.
Results and discussion
Synthesis of phenylethylamines can be performed in a number of
ways. One of the most usual strategies is based on the nitroaldolic
condensation (Henry reaction) of a nitroalkane with an aromatic
aldehyde10 followed by LAH reduction of the corresponding
nitroalkene. Alternatively, they can be obtained by reductive
amination of the corresponding aldehydes or ketones through
the intermediate formation of an imine, an iminium salt or an
enamine.11 The main advantage of the reductive amination vs.
the Henry reaction is that the former can be performed in a
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1 1a 2a, 83 4a, 77
2 3a — 4a, 75b
3 1b 2b, 74 4b, 77
4 3b — 4b, 70b
5 1c 2c, 92 4c, 82
6 1d 2d, 71 4d, 80
7 1e 2e, 85 4e, 73
8 1f 2f, 79 4f, 71
9 1g 2g, 94 4g, 86
10 3h — 4h, 89b
11 4g — 4i, 85c
12 Cyclohexanecarbaldehyde 84 5, 87
a By reduction of nitroalkenes 2 unless noted otherwise. b By reductive
amination. c By cleavage of the methoxy amine 4g.
one-pot reaction. Following these two strategies, a series of
different phenylethylamines 4a–4h was prepared for subsequent
enzymatic resolution (Scheme 1).
As shown in Table 1, amines 4 were obtained in good isolated
yields, the reductive amination process affording clearly better
overall yields when the starting ketone 3 was commercially
available (compare entries 1–2 and 3–4). Preparation of 1-
(4¢-hydroxy)phenyl-2-propanamine (4i)was performedby cleavage
of methoxy derivative 4g in reﬂuxing HBr (Scheme 2).12 In this
case, we had to overcome serious problems in the extraction
process because 4iwas obtained as a salt at several pHs considered.
Successful recovery of the product was achieved by adjusting the
crude to pH 9, and the aqueous layer subjected to a continuous
liquid–liquid extraction with AcOEt. Amine 4i was thus obtained
in 85% yield (entry 11). 1-Cyclohexyl-2-propanamide (5) was
obtained from the corresponding cyclohexanecarbaldehyde in
73% overall yield (entry 12).
Scheme 2 Synthesis of amines 4i and 5.
When the racemic amines were available, two possibilities
emerged for their enantiomeric resolution: the classical resolution
by crystallization of the diastereomeric salts and the enzymatic
resolution. We initially tested formation of the corresponding
diastereomeric salts using (L)-(+)-tartaric acid as the resolving
agent.13 However, after several trials for the resolution of amine
4g, only a 45% yield and 30% ee of theR enantiomer was obtained
using a 1 : 2 amine : tartaric acid molar ratio. Consequently, the
enzymatic resolution appeared to be an alternative and attractive
choice.
A wide range of chiral amines has been successfully resolved
using Candida antarctica lipase type B (CAL-B), a highly
enantioselective and reliable biocatalyst for this purpose,14 and,
therefore, our ﬁrst candidate for the enzymatic resolution of
amines 4a–i (Scheme 3). It is well known that selection of the
appropriate acyl donor is crucial for the kinetic resolution of
amines.15 In this context, ethyl acetate is probably the most
commonly used acylating agent because of its low cost, easy
handling, and suitability as organic solvent for the biotransfor-
mation. Thus, Gonzalez-Sabin et al.11b successfully resolved o-,
m-, and p-methoxyamphetamines using CAL-B and ethyl acetate
in good yields and excellent enantioselectivities. However, in our
case preliminary trials using ethyl acetate afforded only moderate
enantioselectivities of amines 4g and 4d (entries 1, 5; Table 2).
Therefore, we chose the more activated ethyl methoxyacetate as
an acyl donor. The methoxy substituent increases the carbonyl
activity so that the initial acylation rate also increases. In addition,
it does not favor other non-enzymatic side reactions as other highly
activated acyl donors do, such as trichloroacetic acid esters.16 In
all experiments triethylamine was used as non-nucleophilic base
to enhance the reaction rate and the enantioselectivity of the
process.17
Scheme 3 Enzymatic resolution of racemic amines 4a–i.
To ﬁnd the optimal experimental conditions for the resolution
of the model amine 4g, we considered the relative amount
of enzyme vs. substrate, temperature of the biotransformation
and the presence or not of solvent (heptane) (Table 2). The
highest enantiomeric purity of the (R)-amide (99%) and the
corresponding (R)-amine (93%)was achievedbyusing amixture of
ethyl methoxyacetate, heptane and triethylamine (0.1/10/0.02 ml
mmol-1 substrate) at 35 ◦C (entry 2). When these conditions were
applied at 50 ◦C, the less reactive (S)-amine was obtained in an
excellent 97% ee but the ee of the desired (R)-amine dropped
to 87% (entry 3). Therefore, since the ee of the (S)-amine could
be improved by a sequential second resolution, we selected the
conditions of entry 2 for the resolution of the remaining amines.
As cited, the more reactive enantiomer had the R conﬁguration,
in agreement with a model originally developed to predict the
preferentially acylated enantiomer of secondary alcohols.18
When these conditions (entry 2, Table 2) were applied to amine
4d, the reaction ratewas too high to stop the conversion at 50% in a
reproducible manner (not shown). Therefore, the relative amount
of the enzyme was reduced from 200 to 40 mgmmol-1 of substrate.
Under these conditions, (R)-4d was obtained in 95% ee and an
enantioselectivity ratio E = 88 (entry 7, Table 2). Removal of Et3N
or lowering the temperature to 25 ◦C resulted in similar yields
but lower enantioselectivities of the more reactive amine (entries
8–9, Table 2). The ee of the (R)-amides 6d–6g was determined by










































































(%)a t (h) Yield eeb Yield eec Yieldd eeb Ee
1 4g CH3CO2Et/Et3N 50 35 —f 5 48 43 37 89g 72 85 19
3/0.02
2 4g CH3OCH2CO2Et/heptane/Et3N 200 35 49 1.5 36 62 38 99 70 93 52
0.1/10/0.02
3 4g CH3OCH2CO2Et/heptane/Et3N 200 50 51 25 40 97 49 90 70 87 59
0.1/10/0.02
4 4g CH3OCH2CO2Et/heptane/Et3N 200 80 51 5 21 79 60 80 53 79 20
0.1/10/0.02
5 4d CH3CO2Et/Et3N 50 35 41 7 47 53 43 ND 38 71 10
3/0.02
6 4d CH3OCH2CO2Et/Et3N 40 35 47 0.8 51 76 51 ND 68 77 17
3/0.02
7 4d CH3OCH2CO2Et/heptane/Et3N 40 35 48 2.7 50 75 45 95 73 95 88
0.1/10/0.02
8 4d CH3OCH2CO2Et/heptane 40 35 40 4 33 76 38 ND 66 81 21
0.1/10
9 4d CH3OCH2CO2Et/heptane/Et3N 40 25 45 6.25 48 65 43 92 74 90 37
0.1/10/0.02
a Calculated by direct integration of the amide/amine peaks in GC. b Calculated by 19F NMR after derivatization with (S)-(+)-a-methoxy-a-
triﬂuoromethylphenylacetyl chloride.19 c Determined by chiral HPLC on a CHIRALPACK IA column, except for amine 4g in entry 1. d Yield of
hydrolysis of the corresponding (R)-amide. e Enantiomeric ratio (E) values were determined from the ee’s of the residual and reacted amines.26 f Controlled
by TLC. g Calculated by comparison with the speciﬁc rotation found in literature.27
chiral HPLC by comparison of their chromatographic behavior
with that of the racemic amides. However, since hydrolysis of
these chiral amides to the corresponding (R)-amines occurredwith
equal or less than 6% racemization, it was considered unnecessary
to analyze the chiral purity of the remaining amides by HPLC.
Therefore, we hydrolysed all amides with base and determined
the ee values of the resulting (R)-amines by conversion to their
Mosher amides followed by 19F NMR.19
When the optimized conditions (entry 7, Table 2) were applied
for the resolution of the remaining amines, compounds 4a, 4f
and 5 gave the corresponding (R)-amines in good yields and
enantioselectivities (see below) but the amines with electron-
withdrawing groups (4e: R = CF3; 4b: R = F; 4c: R = Cl; 4h: R =
NO2) remained unreactive. Therefore, new optimization studies
were performed for these types of substrates taking amine 4e
as representative example (Table 3). Using ethyl methoxyacetate
as a cosolvent (entry 1), the conversion rate of amine 4e was
enhanced to 43% in 4 h reaction but the ee of the R amine
was only moderate (80%). Removal of heptane in the solvent
mixture markedly improved the ee of (R)-4e to 93% and the
enantioselectivity ratio to E = 64 (entry 2). Lower or higher
temperatures did not substantially modify this result (entries 3–5;
Table 3).
As cited above, compounds 4a, 4f and 5 were subjected to the
conditions of entry 7, Table 2 to give the (R)-amines in excellent
enantioselectivity (92–99% ee, E = 50–382) (entries 1, 7, 11;
Table 4). Amines 4b, 4c, 4e with moderate electron-withdrawing
groups were successfully resolved using the conditions stated
in entry 2, Table 3 in 90–93% ee (entries 3, 4, 6; Table 4),
whereas amine 4h with the strongest deactivating nitro group, was
absolutely inert under these conditions (not shown). Themoderate
enantioselectivity towards the residual substrate (amines (S)-4a–
4g, and (S)-5) could be the result of some racemization under the
enzymatic conditions used. Particularly interesting was resolution
of amine 4i because the (S)-amine resulted completely racemic
(entry 9, Table 4), inconsistent with the degree of conversion
(50%) and the high enantioselectivity for the R enantiomer (96%
ee). To conﬁrm this unexpected result, a new resolution with an
increased conversion (71%) was performed. This would result in
an increase of the enantioselectivity towards the (S)-amine and a
decrease of the (R)-amine ee. However, again, the S enantiomer
was obtained in practically racemic form and the R was of high
enantiomeric purity (95% ee) (entry 10, Table 4). At ﬁrst sight,
this process could be explained in terms of a dynamic kinetic
resolution (DKR), which allows a theoretical 100% yield of the
more reactive enantiomer by racemization of the slow-reacting
enantiomer.20 However, the classical DKR implies an in situ
racemization of the substrate prior to the enzymatic reaction, but
racemization of unfunctionalized amines is difﬁcult and requires
harsh conditions. This is the reason why very few examples of
DKR of amines have been described so far. DKR of racemic
phenylethylamine has been reported to occur by CAL-B after
8 days reaction in the presence of Pd/C,21 and other primary
amines by the same enzyme in the presence of a ruthenium catalyst
in toluene at 90 ◦C22 or a palladium nanocatalyst at 100 ◦C.23
Very recently, a radical racemization with triﬂuoroethanethiol
followed by an enzymatic resolution mediated by alkaline pro-
tease has been reported.24 Remarkably, in our case racemization
occurs without need of any metal catalyst and under very mild
conditions.










































































(%)a t (h) Yield eeb Yield eec Yieldd eeb Ee
1 CH3OCH2CO2Et/heptane/Et3N 40 35 43 4 42 30 40 84 60 80 12
4/6/0.02
2 CH3OCH2CO2Et/Et3N 40 35 45 1.5 51 77 41 ND 72 93 64
4/0.02
3 CH3OCH2CO2Et/Et3N 40 15 38 36 45 20 35 ND 68 80 11
4/0.02
4 CH3OCH2CO2Et/Et3N 40 25 43 1.5 53 75 38 ND 66 93 62
4/0.02
5 CH3OCH2CO2Et/Et3N 40 50 41 0.5 52 41 38 ND 68 86 20
4/0.02
a Calculated by direct integration of the amide/amine peaks in GC. b Calculated by 19F NMR after derivatization with (S)-(+)-a-methoxy-a-
triﬂuoromethylphenylacetyl chloride.19 c Determined by chiral HPLC on a CHIRALPACK IA column. d Yield of hydrolysis of the corresponding
(R)-amide. e Enantiomeric ratio (E) values were determined from the ee’s of the residual and reacted amines.26







Entry Amine Conditions Conversion (%)a t (h) Yield eeb Yield eec Yieldd eeb Ee
1 4a entry 7; Table 2 42 2.6 40 70 49 ND 59 92 50
2 4af entry 7; Table 2 45 2.6 41 73 47 ND 68 91 46
3 4b entry 2; Table 3 40 5.5 55 48 35 ND 72 90 31
4 4c entry 2; Table 3 40 5.5 50 45 38 ND 79 92 37
5 4d entry 7; Table 2 48 2.7 50 75 45 94 73 95 88
6 4e entry 2; Table 3 45 1.5 51 77 41 ND 72 93 64
7 4f entry 7; Table 2 48 2.5 50 71 42 97 65 96 104
8 4g entry 2; Table 2 49 1.5 36 62 38 99 70 93 52
9 4i entry 2; Table 3 50 24 36 0 47 ND 53 96 49
10 4i entry 2; Table 3 71 96 20 5 67 ND 50 95 41
11 5 entry 7; Table 2 42 2 45 63 38 ND 75 99 382
a Calculated by direct integration of the amide/amine peaks in GC. b Calculated by 19F NMR after derivatization with (S)-(+)-a-methoxy-a-
triﬂuoromethylphenylacetyl chloride.19 c Determined by chiral HPLC on a CHIRALPACK IA column. d Yield of hydrolysis of the corresponding
(R)-amide. e Enantiomeric ratio (E) values were determined from the ee’s of the residual and reacted amines.26 f Kinetic resolution of amine 4a at a 10 g
scale.
Further experiments were conducted to establish how the
racemization of (S)-4iwas taking place. Thus, two enantioenriched
samples of (R)-4i (S)-4i with different enantiomeric ratios (R :S =
96 : 4 and 26 : 74, respectively) were prepared, the former by enzy-
matic resolution and the latter by diastereomeric salt formation
and crystallization.25 These substrates were subjected to different
resolution experiments in which either the acyl donor, catalyst or
the enzyme were suppressed. In no case was there conversion of
the amine into the corresponding amide and, thus, the ee of the
unreacted amines remained unaltered in all reactions. Therefore,
all reagents were necessary for the resolution and none of them
responsible for the racemization of amine (S)-4i. Additional
studies are necessary to shed some light on the mechanism of this
particular racemization, which could be related to the ionization
state of this amphiprotic substrate affecting its solubility in the
reaction medium.
To test the possible scalability of the enzymatic resolution,
amine 4a (10 g, 74 mmol) was subjected to the conditions of
entry 7, Table 2. The results (entry 2, Table 4) in terms of the ee’s
of both chiral amines and the enantioselectivity (E) of the process
were similar to previously obtained in small scale, proving that the
enzymatic procedure can be scaled up without loss of yield and
enantioselectivity.
To obtain the (S)-amines in almost enantiomerically pure
state, a second sequential kinetic resolution of the (S)-
enantioenriched amines 4a–f and 5 was undertaken. The process
occurred as expected under the conditions speciﬁed in Table
5 in moderate to good yields and excellent enantioselectivities
(90–99% ee).
Conclusions
Several primary amines, structurally related to amphetamine
analogues, have been synthesized and subjected, some of them
for the ﬁrst time, to enzymatic kinetic resolution using CAL-B
and ethyl methoxyacetate as the acyl donor. Although successful
resolution has not been attained under identical conditions for
all amines, both enantiomers have been obtained in good yields
and excellent ee. Particularly interesting is the case of amine 4i
(R = OH), whose S enantiomer racemizes possibly in a DKR




























































Table 5 Sequential kinetic resolution of (S)-enantioenriched amines 4a–f and 5
(S)-Amine (%)
Entry Amine Initial S :R ratio Conditions Conversion (%)a Yield eeb
1 4a 85 : 15 entry 6; Table 2 15 1.3 63 96
2 4b 74 : 26 entry 2; Table 3 36 5 62 92
3 4c 60 : 40 entry 2; Table 3 48 4 49 92
4 4d 75 : 25 entry 6; Table 2 24 1 52 98
5 4e 69 : 31 entry 2; Table 3 32 1.5 59 90
6 4f 85 : 15 entry 6; Table 2 22 1.7 70 96
7 5 82 : 18 entry 6; Table 2 17 1 78 99
a Calculated by direct integration of the amide/amine peaks in GC. b Calculated by 19F NMR after derivatization with (S)-(+)-a-methoxy-a-
triﬂuoromethylphenylacetyl chloride.19




All solvents were dried and distilled according to standard
procedures. IR spectra were recorded on a Nicolet Avatar 360
FT-IR spectrometer. Kinetic resolutions were monitored by GC
on a HP-5 (25 m ¥ 0.20 mm ¥ 0.33 mm) fused silica capillary
column. NMR spectra were recorded at 300, 400, or 500 MHz for
1H, 75 or 100MHz for 13C, and 282MHz for 19F on a VarianUnity
300, VarianMercury 400, or Varian Inova 500 spectrometer.Mass
spectra (MS) were obtained on a Fisons MD 800 spectrometer.
HRMS were run on a UPLC Acquity (Waters, USA) coupled to
a mass spectrometer LCT Premier XE (Waters, USA).
Optical rotations were measured on a Perkin Elmer 341
polarimeter. The enantiomeric excess of chiral amines was deter-
mined by 19F NMR after derivatization with (S)-(+)-a-methoxy-
a-triﬂuoromethylphenylacetyl chloride (2 equiv.), DMAP and
triethylamine.19 The enantiomeric purity of chiral amides was
determined by chiral HPLC using a CHIRALPACK IA column
(25 ¥ 0.46 cm) at 0.5 ml min-1 of isopropanol : hexane 10 : 90
(isocratic conditions).
Nitrostyrenes 2a,28 2b,29 2c,30 2d,31 2e,32 2f,33 2g,33 and the
precursor34 of amine 5 were prepared from the corresponding
aldehydes with nitroethane under reﬂux in 71–94% isolated yields
after recrystallization in EtOH/hexane.
Preparation of amines 4a–g and 5 by reduction of the correspond-
ing nitrostyrenes. A solution of the precursor nitro compound
(2.61 mmol) in 20 ml of anh. Et2O was slowly added with
continuous stirring to a solution of LiAlH4 (0.40 g, 10.45 mmol)
in 20 ml of anh. Et2O under Ar. After the addition, the solution
was reﬂuxed for 3 h. The reaction was allowed to cool to 0 ◦C and
quenched by slow addition of 0.4 ml of H2O, 0.4 ml of 15%NaOH
aq. soln. and 1.2 ml of H2O. The lithium and aluminum salts were
ﬁltered off and washed with Et2O. The crude amine was distilled
under reduced pressure in a Kugelrohr apparatus.
1-Phenyl-2-propanamine (4a),35 77% yield.
1-(4¢-Fluoro)phenyl-2-propanamine (4b),11a 77% yield.
1-(4¢-Chloro)phenyl-2-propanamine (4c),36 82% yield.
1-(4¢-Bromo)phenyl-2-propanamine (4d),31 80% yield.
1-(4¢-Triﬂuoromethyl)phenyl-2-propanamine (4e),37 73% yield.
1-(4¢-Methyl)phenyl-2-propanamine (4f),38 71% yield.
1-(4¢-Methoxy)phenyl-2-propanamine (4g),11b 86% yield.
1-Cyclohexyl-2-propanamine (5),39 87% yield.
Preparation of 1-(4¢-hydroxy)phenyl-2-propanamine (4i) by cleav-
age of 4g. A mixture of amine 4g (2.5 g, 15.15 mmol) in 21 ml
of 45% HBr was heated at reﬂux for 3 h. The neutral materials
were separated by extraction with AcOEt, the pH was adjusted to
9 by adding solid KOH and the aqueous solution was subjected
to continuous liquid–liquid extraction with AcOEt for 24 h. The
organic layer was dried with anh. MgSO4 and concentrated to
yield amine 4i40 as a yellow waxy solid (1.9 g, 85%).
Preparation of amines 4a–b and 4h by reductive amination of
ketones 3a–b and 3h. A mixture of the corresponding ketone 3a–
b and 3h (10 mmol), titanium(IV) isopropoxide (6.0 ml, 20 mmol)
and a 7 N NH3 soln. in methanol (25 ml, 50 mmol) was stirred
under Ar at room temperature for 6 h. Solid sodium borohydride
(0.56 g, 15 mmol) was then added and the resulting mixture was
stirred at room temperature for an additional 3 h. The reaction
was then quenched by pouring into 25% NH4OH soln. (25 ml),
the resulting inorganic precipitate was ﬁltered off and washed
with AcOEt. The combined aqueous and organic layers were
acidiﬁed with 1 M HCl and extracted with AcOEt to separate the
neutralmaterials. The aqueous extract was treatedwith solidKOH
to pH 10 and repeatedly extracted with AcOEt. The combined
extracts were washed with brine, dried with anhydrous MgSO4,
and concentrated under vacuum to afford the corresponding
amine.
1-Phenyl-2-propanamine (4a),35 75% yield. The spectroscopic
data were identical to those of the compound obtained by
reduction of nitrostyrene 2a.
1-(4¢-Fluoro)phenyl-2-propanamine (4b),11a 70% yield. The spec-
troscopic data were identical to those of the compound obtained
by reduction of nitrostyrene 2b.
1-(4¢-Nitro)phenyl-2-propanamine (4h),41 89% yield.
Enzymatic kinetic resolution of amines 4a–g, 4i and 5. General
procedure
A solution of amine (1.00 mmol), C. antarctica lipase B
(CAL-B, Novozym 435) (40–200 mg) and a mixture of anh.
CH3OCH2CO2Et/heptane/Et3N in the required ratio was placed
underN2 in a thermostated bath at 35 ◦Cand shaken at 80Umin-1.




























































The reaction was monitored by GC and when the transformation
was ca. 50% the mixture was ﬁltered off, and the enzyme washed
with ethyl acetate, CH2Cl2 and MeOH. The solvent was stripped
off and the resulting crude dissolved in CH2Cl2, acidiﬁed with 6
N HCl and repeatedly extracted with CH2Cl2 to afford the (R)-
amide. The aqueous layer was then adjusted to pH 10 with solid
KOH and extracted with CH2Cl2, dried with anh. MgSO4 and
concentrated to yield the (S)-amine.
To obtain the (R)-amine, the (R)-amide (1.00 mmol) was
subjected to hydrolysis with 3 M KOH (30 ml, 89 mmol) at
reﬂux overnight.17 The reaction mixture was acidiﬁed to pH 1
with 6 N HCl and extracted with CH2Cl2 to remove the neutral
material. The aqueous layer was treated again with solid KOH
to pH 10, extracted with CH2Cl2, dried over anh. MgSO4 and
concentrated under reduced pressure to yield the (R)-amine. The
spectroscopic datawere identical to those described for the racemic
amines.
The enantioenriched (S)-amines resulting from the enzymatic
resolution were subjected to a second kinetic resolution under the
conditions stated in Table 5 to yield the expected amines in 52–
78% isolated yields and 90–99% ee. The spectroscopic data were
identical to those described for the racemic amines.
The resolution procedure was scaled up to 10 g (74 mmol) of
amine 4a with similar conversion (45%) and ee of the resulting
chiral amines ((S)-4a, 41% yield, 73% ee; (R)-4a, 68% yield after
hydrolysis of the amide, 91% ee).
(R)-(-)-1-Phenyl-2-propanamine [(R)-4a],42 29% overall yield,
92% ee, [a]20D -26.8 (c 1.1, CHCl3).
(S)-(+)-1-Phenyl-2-propanamine [(S)-4a],43 63% yield, 96% ee,
[a]20D = +27.5 (c 1.2, CHCl3).
(R)-(-)-1-(4¢-Fluoro)phenyl-2-propanamine [(R)-4b],44 25% over-
all yield, 90% ee, [a]20D -23.2 (c 1.1, CHCl3).
(S)-(+)-1-(4¢-Fluoro)phenyl-2-propanamine [(S)-4b],44 62%yield,
92% ee, [a]20D = +25.2 (c 1.4, CHCl3).
(R)-(-)-1-(4¢-Chloro)phenyl-2-propanamine [(R)-4c],45 30%over-
all yield, 92% ee, [a]20D -26.1 (c 0.9, CHCl3).
(S)-(+)-1-(4¢-Chloro)phenyl-2-propanamine [(S)-4c],45 49%
yield, 92% ee, [a]20D = +25.0 (c 1.1, CHCl3).
(R)-(-)-1-(4¢-Bromo)phenyl-2-propanamine [(R)-4d],46 33%over-
all yield, 95% ee, [a]20D -28.5 (c 1.2, CHCl3).
(S)-(+)-1-(4¢-Bromo)phenyl-2-propanamine [(S)-4d],46 52%
yield, 98% ee, [a]20D = +27.0 (c 1.2, CHCl3).
(R)-(-)-1-(4¢-Triﬂuoromethyl)phenyl-2-propanamine [(R)-4e],47
30% overall yield, 93% ee, [a]20D -23.5 (c 1.2, CHCl3).
(S)-(+)-1-(4¢-Triﬂuoromethyl)phenyl-2-propanamine [(S)-4e]
59% yield, 90% ee, [a]20D = +22.2 (c 1.1, CHCl3).
(R)-(-)-1-(4¢-Methyl)phenyl-2-propanamine [(R)-4f], 27% over-
all yield, 96% ee, [a]20D -33.9 (c 1.1, CHCl3).
(S)-(+)-1-(4¢-Methyl)phenyl-2-propanamine [(S)-4f] 70% yield,
96% ee, [a]20D = +35.0 (c 1.6, CHCl3).
(R)-(-)-1-(4¢-Methoxy)phenyl-2-propanamine [(R)-4g],48 27%
overall yield, 93% ee, [a]20D -27.8 (c 0.7, MeOH); lit.27 = -29.5
(c 1.0, MeOH).
(S)-(+)-1-(4¢-Methoxy)phenyl-2-propanamine [(S)-4g],48 40%
yield, 97% ee, [a]20D = +29.1 (c 1.0, MeOH); lit.27 = +29.5 (c 1.0,
MeOH).
(R)-(-)-1-(4¢-Hydroxy)phenyl-2-propanamine [(R)-4i], 33%over-
all yield, 95% ee, [a]20D -45.9 (c 0.5, EtOH); lit.49 = -52.0 (c 0.8,
EtOH).
(R)-(-)-1-Cyclohexyl-2-propanamine [(R)-5],50 29%overall yield,
99% ee, [a]20D -7.0 (c 1.2, CHCl3).
(S)-(+)-1-Cyclohexyl-2-propanamine [(S)-5],51 78% yield, 99%
ee, [a]20D = +7.1 (c 0.8, CHCl3).
Synthesis of amides 6d–g
To a solution of amine 6d–g (0.61 mmol) in dry THF (1.5 ml)
was added Et3N (0.61 mmol) under N2. The resulting solution
was cooled to 0 ◦C, and methoxyacetyl chloride (0.91 mmol)
was carefully added.52 The mixture was allowed to warm to room
temperature and stirred overnight until no starting material was
detected by TLC. The organic solvent was evaporated under
reduced pressure and the reaction crude was puriﬁed by ﬂash
chromatography (hexane :AcOEt 1 : 1) to yield the corresponding
amide.
N - [2 - (4¢ -Bromophenyl) -1 -methylethyl] -2 -methoxyacetamide
(6d), 82% yield. 1HNMR(300MHz, CDCl3): d 7.41 (d, J = 8.4Hz,
2H); 7.06 (d, J = 8.1 Hz, 2H); 6.34 (d, J = 7.2 Hz, 1H); 4.27 (m,
1H); 3.83 (d, J = 3.0 Hz, 2H); 3.36 (s, 3H); 2.83 (dd, J1 = 13.5 Hz,
J2 = 6.0 Hz, 1H); 2.67 (dd, J1 = 13.8 Hz, J2 = 7.2 Hz, 1H); 1.14 (d,
J = 6.6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): d 168.8 (C);
136.7 (C); 131.4 (2CH); 131.1 (2CH); 120.3 (C); 71.9 (CH2); 59.0
(CH3); 45.3 (CH); 41.8 (CH2); 19.9 (CH3) ppm. IR (ﬁlm) n: 3407,
3298, 2972, 2930, 2343, 1667, 1531, 1489, 1198, 1115, 1071, 1012,
798 cm-1. MS (EI) m/z (%): 287 [(M + 2)+, 1)]; 285 [(M)+, 1]; 196
(25); 169 (24); 116 (100); 90 (34); 56 (63); 45 (78). HRMS Calcd
for C12H17NO2Br (M+): 286.0443; Found: 286.0447.
N-[2-(4¢-Triﬂuoromethylphenyl)-1-methylethyl]-2-methoxyacet-
amide (6e), 87% yield. 1H NMR (300 MHz, CDCl3): d 7.54 (d, J =
8.1 Hz, 2H); 7.30 (d, J = 8.1 Hz, 2H); 6.37 (d, J = 7.5 Hz, 1H); 4.34
(m, 1H); 3.83 (d, J = 3.3 Hz, 2H); 3.36 (s, 3H); 2.94 (dd, J1 = 13.5
Hz, J2 = 6.3 Hz, 1H); 2.78 (dd, J1 = 13.5 Hz, J2 = 7.2 Hz, 1H); 1.13
(d, J = 6.6 Hz, 3H) ppm. 13C NMR (75MHz, CDCl3): d 168.7 (C);
141.9 (C); 129.6 (2CH); 128.8 (q, J = 32.5 Hz, CCF3); 125.3 (q,
J = 3.7 Hz, 2CH); 124.2 (q, J = 270.4 Hz, CF3); 72.0 (CH2); 59.0
(CH3); 45.3 (CH); 42.4 (CH2); 19.9 (CH3) ppm. 19F NMR (282
MHz, CDCl3): d -62.86 (s) ppm. IR (ﬁlm) n: 3306, 2934, 2359,
1665, 1533, 1325, 1151, 1067, 1019, 817 cm-1. MS (EI) m/z (%):
275 (M+, 1); 186 (7); 159 (57); 116 (98); 56 (73); 45 (100). HRMS
Calcd for C13H17NO2F3 (M+): 276.1211; Found: 276.1216.
N - [2 - (4¢ -Methylphenyl) -1-methylethyl] -2-methoxyacetamide
(6f), 91% yield. 1H NMR (300 MHz, CDCl3): d 7.08 (m, 4H); 6.40
(d, J = 6.9 Hz, 1H); 4.25 (m, 1H); 3.83 (d, J = 4.8 Hz, 2H); 3.35
(s, 3H); 2.77 (dd, J1 = 13.5 Hz, J2 = 6 Hz, 1H); 2.67 (dd, J1 =
13.5 Hz, J2 = 7.2 Hz, 1H); 2.32 (s, 3H); 1.14 (d, J = 6.6 Hz, 3H)
ppm. 13C NMR (75 MHz, CDCl3): d 168.7 (C); 136.1 (C); 134.7
(C); 129.4 (2CH); 129.2 (2CH); 72.1 (CH2); 59.2 (CH3); 45.7 (CH);
42.2 (CH2); 21.1 (CH3); 20.1 (CH3) ppm. IR (ﬁlm) n: 3412, 3305,
2925, 2362, 1671, 1528, 1452, 1197, 1115, 984, 804 cm-1. MS (EI)
m/z (%): 221 (M+, 1); 132 (67); 116 (74); 105 (53); 45 (100). HRMS
Calcd for C13H20NO2 (M+): 222.1494; Found: 222.1490.
N -[2-(4¢-Methoxyphenyl)-1-methylethyl]-2-methoxyacetamide
(6g), 79% yield. 1H NMR (300 MHz, CDCl3): d 7.09 (d, J = 8.4
Hz, 2H); 6.82 (d, J = 8.7 Hz, 2H); 6.36 (d, J = 7.5 Hz, 1H); 4.25 (m,
1H); 3.83 (d, J = 4.8 Hz, 2H); 3.78 (s, 3H); 3.35 (s, 3H); 2.79 (dd,
J1 = 13.5 Hz, J2 = 6.0 Hz, 1H); 2.66 (dd, J1 = 13.8 Hz, J2 = 7.2 Hz,
1H); 1.12 (d, J = 6.6 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3):
d 168.7 (C); 158.2 (C); 130.3 (2CH); 129.9 (C); 113.7 (2CH); 71.9




























































(CH2); 59.1 (CH3); 55.2 (CH3); 45.6 (CH); 41.7 (CH2); 19.9 (CH3)
ppm. IR (ﬁlm) n: 3307, 2931, 1661, 1612, 1583, 1512, 1246, 1033
cm-1. MS (EI) m/z (%): 237 (M+, 1); 148 (69); 121 (45); 116 (32);
91 (13); 78 (18); 56 (59); 45 (100). HRMS Calcd for C13H20NO3
(M+): 238.1443; Found: 238.1435.
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